SWE Liver Stiffness as a Predictor of Progression of Chronic Liver Diseases

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

2148 participants

Study Classification

OBSERVATIONAL

Study Start Date

2007-07-26

Study Completion Date

2019-11-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is a multicenter individual patient-based meta-analysis that will assess the performances of liver stiffness measurements performed with supersonic shear imaging shearwave elastography (SSI-SWE) in patients with liver fibrosis to predict progression of chronic liver disease.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Liver and Spleen Stiffness Measured by 2D-SWE for Diagnosis of Liver Fibrosis in Patients With cACLD

NCT06147934

Liver Fibrosis Liver Cirrhosis

RECRUITING

Liver Fibrosis Assessment With ShearWave Elastography

NCT02181452

Liver Fibrosis

COMPLETED

Prospective Comparison Between TE, SWE and MRE (FULLFIBRO01)

NCT03293953

Liver Fibrosis

UNKNOWN

ShearWave™ Elastography to Assess Liver Fibrosis in Chinese Patients With Hepatitis B

NCT02313649

Liver Fibrosis

COMPLETED

Assessment of Hepatic Fibrosis by Shear Wave Elastography in Patients With Liver Malignancy: A Prospective Single-center Study

NCT02958592

Liver Tumor Hepatic Fibrosis

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Liver Fibroses

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Elastography

liver stiffness measurements by shear wave-based elastography

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients who had received a liver ultrasound exam at baseline for a suspected chronic fibrotic liver disease of viral and/or steatotic origin,
* Patients who had reached the age of majority in their countries, at baseline,
* Patients with a baseline liver biopsy for histological evaluation of liver fibrosis with a length ≥ 15 mm paraffin sections (except if cirrhosis),
* Patients for whom a minimum length of clinical follow-up from baseline of 1 year had been recorded

Exclusion Criteria

* Cause of chronic liver disease other than viral, ALD or NAFLD ( hemochromatosis, autoimmune hepatitis, biliary tract disease intrahepatic...)
* Any systemic, viral hepatitis and HIV co-infection

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No